Neurocrine Biosciences Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

31.74%

Market Cap

-

P/E Ratio

30.38

Dividend Yield

0.00 %

Earnings per Share

4.14 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE142.15 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:56:55 PM
DAILY VOLUME (UNITS)24
DAILY HIGH / LOW142.6131.75
PREV. DAY'S PRICE132.7 (06/02)
CHANGE DAY BEFORE
+9.45
7.12 %
52 WEEK HIGH / LOW142.6 (06/03)102.45 (02/13)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE8.076.684.143.042.29
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO16.6120.0830.3841.4753.29
PRICE - BOOK RATIO--4.365.245.83
PRICE - SALES RATIO--5.086.017.05
PRICE - CASH FLOW RATIO--18.5723.7734.13
Further Key Figures

Master Data

WKN
900964
ISIN
US64125C1099
SYMBOL
NB3
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
NEUROCRINE BIOSCI.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.90 %
27.09 %
17.12 %
10.41 %
31.74 %
54.81 %
73.15 %
9.67 %
HIGH139.70142.60139.70142.60142.60148.65148.65139.70
LOW131.70111.15106.20102.45102.4577.3063.62102.45
Dividend
per share
NEUROCRINE BIOSCI. does not deliver dividend information

Company profile

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.